In summary, preclinical studies using multiple in vitro cell lines and an in vivo mouse model all demonstrated that TR4 has a protective role in suppressing HCC metastasis via downregulating EphA2 expression. The gene discussed is NR2C2; the disease is hepatocellular carcinoma.